NCT03605693

Brief Summary

The overall purpose of this project is to determine the feasibility of conducting a randomized clinical trial that compares written exposure therapy with usual care among patients at risk for cardiovascular event-induced PTSD. Patients hospitalized with acute cardiovascular events, including strokes, heart attacks, and cardiac arrest are at risk of developing post-traumatic stress disorder (PTSD) due to the trauma of the acute medical event. The goal of this study is to test the feasibility of conducting a randomized trial involving a psychological intervention to prevent the development of PTSD symptoms in patients at risk for PTSD. Patients who are admitted with these acute cardiovascular events will first be screened for PTSD risk factors while in-hospital after the index event. These risk factors will include elevated threat perceptions at the time of presentation to the hospital or early symptoms of PTSD due to the cardiovascular event. Patients at elevated risk for PTSD will then be randomized to the intervention group or usual care. Those assigned to the intervention will participate in 5 sessions of written exposure therapy in which they are asked to write about the experience of their cardiovascular event with guidance from a trained study clinician. At 1 month after discharge, all patients will be contacted by phone to complete a questionnaire that assesses PTSD symptoms related to the cardiovascular event. Descriptive statistics will be used to understand the feasibility of testing the written exposure therapy intervention as part of a larger, fully powered clinical trial.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 20, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 30, 2018

Completed
2 days until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2019

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
8 months until next milestone

Results Posted

Study results publicly available

August 26, 2020

Completed
Last Updated

September 16, 2020

Status Verified

August 1, 2020

Enrollment Period

1 year

First QC Date

July 20, 2018

Results QC Date

July 29, 2020

Last Update Submit

August 28, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • PTSD Checklist - Stressor Specific (PCL-S) Score

    This is to measure PTSD symptoms due to the index cardiovascular event. The PCL-S is self-report measure of the symptoms of PTSD. Respondents rate how much they were bothered by 20 symptoms, each rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely), such that total scores range from 0-80. The PCL-S (specific stressor) asks respondents about symptoms in relation to an identified stressful experience. The PCL-S aims to link symptom endorsements to the index cardiovascular event

    1 month after hospital discharge

Secondary Outcomes (4)

  • Number of Subjects Completing the Written Exposure Therapy

    Approximately 1 month after hospital discharge

  • Adherent to Cardiovascular Medications

    Approximately 1 month after hospital discharge

  • PHQ-8 Score

    Baseline, 1 month after hospital discharge

  • Short Form Health Survey Version 2.0 (SF-12v2) Score

    Approximately 6 months after hospital discharge

Study Arms (2)

Early Psychological Intervention

ACTIVE COMPARATOR

Those assigned to Early Psychological Intervention will receive Written Exposure Therapy, a 5 session treatment in which participants write about their trauma event in a specified manner.

Behavioral: Written Exposure Therapy

Usual care

NO INTERVENTION

Those assigned to usual care will complete study assessments but will not be referred to any psychological treatment

Interventions

Written exposure therapy is a 5 session treatment in which participants write about their trauma event in a specified manner.

Early Psychological Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized with acute stroke, TIA, ACS, or cardiac arrest
  • Enrolled in REACH-stroke, PHS, or REACH-cardiac arrest observational cohort studies
  • Elevated ASD symptoms (ASD score \>=28) and/or elevated threat perceptions during index hospitalization (ED threat score \>=12)

You may not qualify if:

  • Unavailable for follow-up for written exposure therapy sessions
  • Unable to read and write in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Behavioral Cardiovascular Health

New York, New York, 10032, United States

Location

Related Publications (1)

  • Sloan DM, Marx BP, Lee DJ, Resick PA. A Brief Exposure-Based Treatment vs Cognitive Processing Therapy for Posttraumatic Stress Disorder: A Randomized Noninferiority Clinical Trial. JAMA Psychiatry. 2018 Mar 1;75(3):233-239. doi: 10.1001/jamapsychiatry.2017.4249.

    PMID: 29344631BACKGROUND

MeSH Terms

Conditions

Acute Coronary SyndromeStrokeHeart ArrestStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Results Point of Contact

Title
Dr. Ian Kronish
Organization
Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center

Study Officials

  • Ian Kronish, MD

    Associate Professor of Medicine, Dept of Med Beh Cardiology

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcomes assessors that assess PTSD symptoms 1 month after discharge (primary outcome) will be blinded to treatment assignment.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Medicine, Dept of Med Beh Cardiology

Study Record Dates

First Submitted

July 20, 2018

First Posted

July 30, 2018

Study Start

August 1, 2018

Primary Completion

August 14, 2019

Study Completion

December 31, 2019

Last Updated

September 16, 2020

Results First Posted

August 26, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will share

De-identified data will be made available upon request to the study prinicipal investigator.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will become available August 1, 2020, and will be available until August 1, 2025.
Access Criteria
For whom: Researchers who provide a methodologically sound protocol. For what analyses: To achieve aims in the approved protocol.

Locations